Maiden Holdings, Ltd. (NASDAQ:MHLD) has been assigned a consensus rating of “Hold” from the six research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $4.50.

Separately, B. Riley lowered their price objective on Maiden from $2.50 to $1.00 and set a “neutral” rating for the company in a report on Tuesday, March 5th.

Shares of Maiden stock opened at $0.62 on Wednesday. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 2.83. Maiden has a fifty-two week low of $0.61 and a fifty-two week high of $9.10.

Maiden (NASDAQ:MHLD) last announced its quarterly earnings data on Friday, March 15th. The insurance provider reported ($2.56) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($2.54). The firm had revenue of $521.71 million during the quarter. Maiden had a negative net margin of 21.64% and a negative return on equity of 97.94%.

In related news, Director Yehuda Neuberger bought 41,716 shares of the firm’s stock in a transaction on Wednesday, March 27th. The stock was bought at an average cost of $0.78 per share, for a total transaction of $32,538.48. Following the completion of the purchase, the director now directly owns 71,100 shares in the company, valued at approximately $55,458. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last three months, insiders purchased 163,633 shares of company stock valued at $130,691. 10.50% of the stock is owned by corporate insiders.

A number of hedge funds have recently modified their holdings of MHLD. Jefferies Group LLC acquired a new position in shares of Maiden during the third quarter worth approximately $132,000. Marshall Wace LLP boosted its position in shares of Maiden by 3,571.9% during the third quarter. Marshall Wace LLP now owns 375,264 shares of the insurance provider’s stock worth $1,070,000 after buying an additional 365,044 shares during the period. GSA Capital Partners LLP boosted its position in shares of Maiden by 285.5% during the fourth quarter. GSA Capital Partners LLP now owns 281,790 shares of the insurance provider’s stock worth $465,000 after buying an additional 208,700 shares during the period. Alliancebernstein L.P. boosted its position in shares of Maiden by 25.4% during the third quarter. Alliancebernstein L.P. now owns 108,095 shares of the insurance provider’s stock worth $308,000 after buying an additional 21,900 shares during the period. Finally, SG Americas Securities LLC boosted its position in shares of Maiden by 455.6% during the fourth quarter. SG Americas Securities LLC now owns 110,427 shares of the insurance provider’s stock worth $182,000 after buying an additional 90,552 shares during the period. Institutional investors own 52.47% of the company’s stock.

Maiden Company Profile

Maiden Holdings, Ltd., through its subsidiaries, provides reinsurance solutions to regional and specialty insurers in the United States, Europe, and internationally. It operates in two segments, Diversified Reinsurance and AmTrust Reinsurance. The Diversified Reinsurance segment offers property and casualty reinsurance, including the writing of treaties on a quota share or excess of loss basis; and facultative risks, which are marketed through third-party intermediaries and on a direct basis.

Further Reading: Special Dividends

Receive News & Ratings for Maiden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maiden and related companies with MarketBeat.com's FREE daily email newsletter.